201 related articles for article (PubMed ID: 26317429)
1. Novel Preparation Methods of (52)Mn for ImmunoPET Imaging.
Graves SA; Hernandez R; Fonslet J; England CG; Valdovinos HF; Ellison PA; Barnhart TE; Elema DR; Theuer CP; Cai W; Nickles RJ; Severin GW
Bioconjug Chem; 2015 Oct; 26(10):2118-24. PubMed ID: 26317429
[TBL] [Abstract][Full Text] [Related]
2. ⁵²Mn production for PET/MRI tracking of human stem cells expressing divalent metal transporter 1 (DMT1).
Lewis CM; Graves SA; Hernandez R; Valdovinos HF; Barnhart TE; Cai W; Meyerand ME; Nickles RJ; Suzuki M
Theranostics; 2015; 5(3):227-39. PubMed ID: 25553111
[TBL] [Abstract][Full Text] [Related]
3. Taking cyclotron
Nelson BJB; Wilson J; Richter S; Duke MJM; Wuest M; Wuest F
Nucl Med Biol; 2020; 80-81():24-31. PubMed ID: 32004935
[TBL] [Abstract][Full Text] [Related]
4. Promises of cyclotron-produced 44Sc as a diagnostic match for trivalent β--emitters: in vitro and in vivo study of a 44Sc-DOTA-folate conjugate.
Müller C; Bunka M; Reber J; Fischer C; Zhernosekov K; Türler A; Schibli R
J Nucl Med; 2013 Dec; 54(12):2168-74. PubMed ID: 24198390
[TBL] [Abstract][Full Text] [Related]
5. Uptake and retention of manganese contrast agents for PET and MRI in the rodent brain.
Brunnquell CL; Hernandez R; Graves SA; Smit-Oistad I; Nickles RJ; Cai W; Meyerand ME; Suzuki M
Contrast Media Mol Imaging; 2016 Sep; 11(5):371-380. PubMed ID: 27396476
[TBL] [Abstract][Full Text] [Related]
6. Chelation chemistry of manganese-52 for PET imaging applications.
Omweri JM; Tekin V; Saini S; Houson HA; Jayawardana SB; Decato DA; Wijeratne GB; Lapi SE
Nucl Med Biol; 2024; 128-129():108874. PubMed ID: 38154167
[TBL] [Abstract][Full Text] [Related]
7. Remote-loading of liposomes with manganese-52 and in vivo evaluation of the stabilities of
Jensen AI; Severin GW; Hansen AE; Fliedner FP; Eliasen R; Parhamifar L; Kjær A; Andresen TL; Henriksen JR
J Control Release; 2018 Jan; 269():100-109. PubMed ID: 29122662
[TBL] [Abstract][Full Text] [Related]
8. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
9. 89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies.
Verel I; Visser GW; Boellaard R; Stigter-van Walsum M; Snow GB; van Dongen GA
J Nucl Med; 2003 Aug; 44(8):1271-81. PubMed ID: 12902418
[TBL] [Abstract][Full Text] [Related]
10. High Yield Production and Radiochemical Isolation of Isotopically Pure Arsenic-72 and Novel Radioarsenic Labeling Strategies for the Development of Theranostic Radiopharmaceuticals.
Ellison PA; Barnhart TE; Chen F; Hong H; Zhang Y; Theuer CP; Cai W; Nickles RJ; DeJesus OT
Bioconjug Chem; 2016 Jan; 27(1):179-88. PubMed ID: 26646989
[TBL] [Abstract][Full Text] [Related]
11. Preparation and preclinical evaluation of (66)Ga-DOTA-E(c(RGDfK))2 as a potential theranostic radiopharmaceutical.
Lopez-Rodriguez V; Gaspar-Carcamo RE; Pedraza-Lopez M; Rojas-Calderon EL; Arteaga de Murphy C; Ferro-Flores G; Avila-Rodriguez MA
Nucl Med Biol; 2015 Feb; 42(2):109-14. PubMed ID: 25316595
[TBL] [Abstract][Full Text] [Related]
12. In vivo evaluation and small-animal PET/CT of a prostate cancer mouse model using 64Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systems.
Garrison JC; Rold TL; Sieckman GL; Figueroa SD; Volkert WA; Jurisson SS; Hoffman TJ
J Nucl Med; 2007 Aug; 48(8):1327-37. PubMed ID: 17631556
[TBL] [Abstract][Full Text] [Related]
13. Tracer level radiochemistry to clinical dose preparation of (177)Lu-labeled cyclic RGD peptide dimer.
Chakraborty S; Sarma HD; Vimalnath KV; Pillai MR
Nucl Med Biol; 2013 Oct; 40(7):946-54. PubMed ID: 23850487
[TBL] [Abstract][Full Text] [Related]
14. In Vivo Labeling of Plasma Proteins for Imaging of Enhanced Vascular Permeability in the Lungs.
Schniering J; Borgna F; Siwowska K; Benešová M; Cohrs S; Hasler R; van der Meulen NP; Maurer B; Schibli R; Müller C
Mol Pharm; 2018 Nov; 15(11):4995-5004. PubMed ID: 30265552
[TBL] [Abstract][Full Text] [Related]
15. Manganese-52 positron emission tomography tracer characterization and initial results in phantoms and in vivo.
Topping GJ; Schaffer P; Hoehr C; Ruth TJ; Sossi V
Med Phys; 2013 Apr; 40(4):042502. PubMed ID: 23556918
[TBL] [Abstract][Full Text] [Related]
16. Comparison of two new angiogenesis PET tracers 68Ga-NODAGA-E[c(RGDyK)]2 and (64)Cu-NODAGA-E[c(RGDyK)]2; in vivo imaging studies in human xenograft tumors.
Oxboel J; Brandt-Larsen M; Schjoeth-Eskesen C; Myschetzky R; El-Ali HH; Madsen J; Kjaer A
Nucl Med Biol; 2014 Mar; 41(3):259-67. PubMed ID: 24417983
[TBL] [Abstract][Full Text] [Related]
17. A unique matched quadruplet of terbium radioisotopes for PET and SPECT and for α- and β- radionuclide therapy: an in vivo proof-of-concept study with a new receptor-targeted folate derivative.
Müller C; Zhernosekov K; Köster U; Johnston K; Dorrer H; Hohn A; van der Walt NT; Türler A; Schibli R
J Nucl Med; 2012 Dec; 53(12):1951-9. PubMed ID: 23139086
[TBL] [Abstract][Full Text] [Related]
18. Cross-sections for (p,x) reactions on natural chromium for the production of (52,52m,54)Mn radioisotopes.
Wooten AL; Lewis BC; Lapi SE
Appl Radiat Isot; 2015 Feb; 96():154-161. PubMed ID: 25497324
[TBL] [Abstract][Full Text] [Related]
19. Radiochemistry, Production Processes, Labeling Methods, and ImmunoPET Imaging Pharmaceuticals of Iodine-124.
Kumar K; Ghosh A
Molecules; 2021 Jan; 26(2):. PubMed ID: 33466827
[TBL] [Abstract][Full Text] [Related]
20. Optimization of reaction conditions for the radiolabeling of DOTA and DOTA-peptide with (44m/44)Sc and experimental evidence of the feasibility of an in vivo PET generator.
Huclier-Markai S; Kerdjoudj R; Alliot C; Bonraisin AC; Michel N; Haddad F; Barbet J
Nucl Med Biol; 2014 May; 41 Suppl():e36-43. PubMed ID: 24361353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
